LANCE RICHARD BRUCK, MD, FACOG, FACS
Chairman
Hugh K. Miller, MD Department of Obstetrics and Gynecology
Stamford Health System
EDUCATION:
1985-1989MuhlenbergCollege
Allentown, PA
Bachelors of Science (Biology and Philosophy)
Magna Cum Laude
1989-1993New YorkMedicalCollege
Valhalla, NY
Medical Degree
POST-GRADUATE TRAINING:
1993-1996Resident, Obstetrics and Gynecology
AlbertEinsteinCollege of Medicine
MontefioreMedicalCenter
JacobiMedicalCenter
Bronx, NY
1995Galloway Fellowship, Gynecologic Oncology
MemorialSloan-KetteringCancerCenter
New York, NY
1996-1997Chief Resident, Obstetrics and Gynecology
AlbertEinsteinCollege of Medicine
MontefioreMedicalCenter
JacobiMedicalCenter
Bronx, NY
PROFESSIONAL EMPLOYMENT:
1996-1998Obstetric and Gynecologic Consultant
Planned Parenthood of NassauCounty
1997Attending Physician - JacobiMedicalCenter
Private Practice Attending Physician – Larchmont, NY
Riker’s Island High Risk Obstetric Consultant – Queens, NY
MontefioreMedicalCenter
1997-2005Medical Director of Women’s Health Services
JacobiMedicalCenter / North Bronx Healthcare Network
1998-2007Director of Gynecology
JacobiMedicalCenter / North Bronx Healthcare Network
2005-2007Director of Gynecologic and Reproductive Health Research
JacobiMedicalCenter / North Bronx Healthcare Network
2006-2007Vice Chairman
Department of Obstetrics, Gynecology and Women’s Health
North Bronx Healthcare Network
2007-presentChairman
Department of Obstetrics and Gynecology
Stamford Health System
HOSPITAL APPOINTMENTS:
1997-2008North Bronx Healthcare Network
JacobiMedicalCenter
NorthCentralBronxHospital
1997-2008Montefiore Medical Center
2007-presentStamford Health System
ACADEMIC APPOINTMENTS:
1997-2000Instructor: Obstetrics, Gynecology and Women’s Health
AlbertEinsteinCollege of Medicine
2000-2006Assistant Professor: Obstetrics, Gynecology and Women’s Health
AlbertEinsteinCollege of Medicine
2001-2007Site Director: Female Pelvic Medicine and Reconstructive Surgery Fellowship Program
AlbertEinsteinCollege of Medicine
2006-presentAssociate Professor: Obstetrics, Gynecology and Women’s
Health
AlbertEinsteinCollege of Medicine
2007Fellowship Director: Gynecologic Endoscopy
Affiliated with the AAGL and SRS
JacobiMedicalCenter
North Bronx Healthcare Network
BOARD CERTIFICATION:
July 1994Diplomate of the National Board of Medical Examiners
November 1999Diplomate of the American Board of Obstetrics and Gynecology
PROFESSIONAL SOCIETY MEMBERSHIP:
Fellow of the AmericanCollege of Obstetricians and Gynecologists
Fellow of the AmericanCollege of Surgeons
American Urogynecologic Society
American Society for Colposcopy and Cervical Pathology
American Association of Gynecologic Laparoscopists
Association of Professors of Gynecology and Obstetrics
Society of Laparoendoscopic Surgeons
AmericanCollege of Physician Executives
Bronx Gynecological and Obstetrical Society
Physicians for Reproductive Choice and Health
Alumni Association of New YorkMedicalCollege
The Martin L. Stone Obstetrical and Gynecological Society
AWARDS AND HONORS:
1989Lindback Scholarship for Academic Excellence and CommunityService
MuhlenbergCollege
1992Schueuer Family Foundation Scholarship
New YorkMedicalCollege
OTHER PROFESSIONAL ACTIVITIES:
1997-2007New York Medical Alliance, PC
Member of the Board of Directors
2002-2007New York Medical Alliance, PC
Corporate Officer
2002-presentPeer Journal Reviewer
Obstetrics and Gynecology
2002-2007Affinity Health Plan
Credentialing and Medical Peer Review Committee
2003-presentRockshelter Consulting, PC
President
2004-presentAmerican Cystoscope Manufacturers, Inc.
Medical Advisory Board
2005-2007Faculty Editor
Einstein Journal of Biology and Medicine
2005-presentGyrus Medical, Inc.
Medical Advisory Board
2005-presentPeer Journal Reviewer The American Journal of Managed Care
2006-presentBoard of Observers
MuhlenbergCollege
2007-presentStamford OB/GYN Associates, PC
President
2007-presentFairfield County OB/GYN, LLC
President
AlbertEinsteincollege of medicine Committees
1997-2007Departmental Committee for Resident Training
1997-2007Ambulatory OB/GYN Elective Leader
1999-2007Dean’s Letter Committee for Medical Students
2001-2007Committee of Admissions
2002-2005Department of Education
Education and Faculty Support Committee
2004-2005Faculty Senate
2006-2007Ad hoc Promotion Chair
GRANT SUPPORT:
A randomized, double-blind, placebo-controlled, parallel-group, multicenter, 12-week study assessing the effects of femhrt on vasomotor symptoms in postmenopausal women of minority ethnic groups.
Protocol#: A4111002. Sponsor: Pfizer. Sub-investigator. $42,062
Comprehensive Family Planning and Reproductive Health Care Services Grant
(2002-2009)
New York State Department of Health. Principal Investigator. $592,429/annum
A multicenter, phase III, double-blind, placebo-controlled, parallel study of ADL 8-2698 in opioid induced postoperative bowel dysfunction/postoperative ileus.
Protocol #: 14CL308. Sponsor: Adolor Corporation. Principal investigator. $102,293
Multi-center, double blind, randomized, placebo-controlled, multiple dose study of the analgesic efficacy and safety of acetaminophen injection 1g vs. placebo for pain following vaginal hysterectomy.
Protocol # 136-03-03. Sponsor: Bristol-Meyers-Squibb. Principal investigator. $36,510
SGN-00101 (HspE7) immunotherapy of CIN III.
Protocol # 5850. Sponsor: CTEP/NIH/Stresgen. Sub-investigator. $15,000
A double-blind, randomized, controlled phase III study to assess the prophylactic efficacy and safety of gD Alum/MPL vaccine in the prevention of genital herpes disease in young women who are HSV-1 and –2 seronegative.
Protocol # 208141/039. Sponsor: NIH/GlaxoSmithKline. Principal investigator. $1,835,740
A double-blind, randomized, controlled study to evaluate the immunogenicity and safety of GlaxoSmithKline biologicals herpes simplex candidate vaccine (gD2-AS04) in healthy HSV seronegative and seropositive female subjects aged 10-17 years.
Protocol # 208141/040. Sponsor: GlaxoSmithKline. Sub-investigator. $ 73,800
An international, randomized, double-blind, placebo-controlled, multicenter, 6-month study of the efficacy and safety of valaciclovir 1g once daily vs. placebo for the suppression of HSV-2 genital herpes in newly infected immunocompetent subjects. Protocol # HS2100275. Sponsor: GlaxoSmithKline. Principal investigator. $24,552
An open-label study of the efficacy and safety of 5 and 10 mg Vesicare (solifenacin succinate) in patients with overactive bladder (OAB) symptoms.
Protocol # 905-UC-007. Sponsor: Yamanouchi Pharma America, Inc.. Principal Investigator. $19,500
Identification of genetic susceptibility loci in women with cervical cancer.
Protocol # K12 RR017672. Sponsor: NIH/NCRR. Sub-investigator. $145,173/annum
(2003-2007)
A randomized, double-blind, placebo-controlled, multi-center, two-way crossover study to investigate the effect of Valtrex 1g once daily for 60 days on viral shedding in HSV-2 seropositive subjects with no previous history of symptomatic genital herpes infection. Protocol # VLX103596. Sponsor: GlaxoSmithKline. Principal Investigator. $27,790
A 12-week, randomized, open-label, parallel-group, multicenter study to evaluate the efficacy, safety and tolerability of Enablex (darifenacin) (with voluntary up-titration from 7.5mg o.d. to 15mg o.d. at week 2) alone or in combination with behavioral modification for symptoms of overactive bladder.
Protocol # CAR328AUS01. Sponsor: Novartis Pharmaceuticals. Principal Investigator. $30,551
A randomized, placebo-controlled phase II study of multiple dosing regimens of intravaginally administered 851B gel for the treatment of cervical high risk HPV infection.
Protocol # 1547-851B. Sponsor: 3M pharmaceuticals. Principal Investigator. $ 129,611
A phase II, randomized, double-blind, placebo-controlled, trial of the use of 4,4 – dinitrophenyl-hydrazone (A-007) topical gel in the treatment of high-grade squamous intraepithelial lesions (HSIL) of the cervix.
Protocol TG-001B. Sponsor: Tigris Pharmaceuticals. Principal Investigator. $ 66,195
A multi-center prospective clinical study to evaluate the performance and clinical predictive value of the Invader® HPV HR Molecular Assay and Invader® HPV 16 / 18 Molecular Assay for the detection of Human Papillomavirus in cervical cytology samples.
Protocol # DP0517. Sponsor: Third Wave Technologies, Inc. Principal Investigator. $87,656
A Phase III Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group, Single- and Multiple-Dose Study of the Analgesic Efficacy and Safety of Intravenous Acetaminophen (IV APAP) Versus Placebo Over 48 Hours for the Treatment of Postoperative Pain after a Total Abdominal Hysterectomy.
Protocol # CPI-APA-301. Sponsor: Cadence Pharmaceuticals, Inc.Principal Investigator.$90,000
A phase IIIb, subject- and observer-blind, randomized, multicenter study with two parallel groups to compare the immunogenicity of GlaxoSmithKline Biological’s HPV-16/18 L1/AS04 vaccine versus Merck’s Gardasil® vaccine when administered intramuscularly according to a 3-dose schedule in healthy adult females 18-45 years of age.
Protocol # 108993/010. Sponsor: GSK Biologicals. Principal Investigator. $80,000
INVITED PRESENTATIONS:
Critical review of the routine postoperative fever evaluation on a gynecologic surgery service. AmericanCollege of Obstetricians and Gynecologists, 1998 Junior Fellow Annual Meeting
Management of ectopic pregnancy. North Bronx Healthcare Network. Bronx, NY. Pediatric Emergency Medicine Grand Rounds. January 1999.
Evaluation and management of urinary incontinence. North Bronx Healthcare Network. Bronx, NY. Internal Medicine Grand Rounds. February 2000.
A review of single dose methotrexate for the treatment of ectopic pregnancy. Health and Hospitals Corporation 2001 Board Meeting
Management of surgical abortion complications. New Insights into Family Planning and Abortion: Enhancing your Gynecologic Practice, 2002 Family Planning Update – New York CityHealth and Hospital Corporation
Detection of cervical human papillomavirus infection by in-situ hybridization in fetuses of women with squamous intraepithelial lesions. The American Society for Colposcopy and Cervical Pathology, 2004 Biennial Meeting
Update on sexually transmitted infections. BayshoreCommunityHospital. Holmdel, NJ. Grand Rounds. July 2005.
The future of OB/GYN as a career path. MuhlenbergCollege. Allentown, PA. Invited alumnus lecturer. November 2005.
Laparoscopic supracervical hysterectomy. EnglewoodHospital. Englewood, NJ. Grand Rounds. January 2006.
Management of adnexal masses. North Bronx Healthcare Network. Bronx, NY. Emergency Medicine Grand Rounds. April 2006.
Cervical dysplasia prevention: HPV vaccination. BronxLebanonHospital. Bronx, NY. Grand Rounds. February 2007.
HPV vaccines: the new era in HPV management. Saint Vincent’s Medical Center- Manhattan. New York, NY. Grand Rounds. April 2007.
HPV and the new vaccine era. StamfordHospital. Stamford, CT. Grand Rounds. May 2007.
Management of Chronic Pelvic Pain. Cablevision- 12 on Health. November 2007
Hope for the Mid-life Female.FairfieldCounty Parish Nurse Grand Rounds. Stamford, CT. May 2008.
Chronic Pelvic Pain – Causes and Treatments. GE Women’s Stay Healthy Lecture Series. Stamford, CT. July 2008.
Course Director:
New Insights into Family Planning and Abortion: Enhancing your Gynecologic Practice, 2002 Family Planning Update – New York City Health and Hospital Corporation. Bronx, NY.
New Technologies in Minimally Invasive Surgery. 2008 Annual Obstetric and Gynecology Symposium – Stamford Health System. Stamford, CT.
BIBLIOGRAPHY:
Original Communications in Reviewed Journals:
Bruck LR, Sherer DM. Intrapartum sonography of the lower uterine segment in patients with breech-presenting fetuses. American Journal of Perinatology 1997;14:315-6.
Cole DS, Bruck LR. Anaphylaxis after laminaria insertion. Obstetrics and Gynecology 2000;95:1025.
Lazarou G, Powers K, Pena C, Bruck L, Mikhail M. Inflammatory reaction following bovine pericardium graft-augmentation for posterior vaginal wall defect repair. International Urogynecology Journal and Pelvic Floor Dysfunction 2005;16:242-244.
Bruck LR, Zee S, Poulos B, Abadi M. Detection of cervical human papillomavirus infection by in situ hybridization in fetuses of women with squamous intraepithelial lesions. Journal of Lower Genital Tract Disease 2005;9:114-117.
Bruck LR, Lazarou G, Mussalli G, Bobby P. Surgical reconstruction of congenital hypertrophy of the perineal body. Journal of Pelvic Medicine and Surgery 2006;12:219-223.
Lazarou G, Powers K, Pena C, Bruck L, Mikhail M. Inflammatory response to bovine pericardium: reply to letter by Davila. International Urogynecology Journal and Pelvic Floor Dysfunction 2006; 17:551.
Abstracts:
Anderson PS, Smith HO, DeVictoria C, Hurde C, Fields AL, Bruck LR, Runowicz CD, Goldberg GL. The potential role of preoperative CA19-9 in patients with endometrial cancer. ACOG 1995 Annual Meeting.San Francisco, CA.
Bruck LR, Cole D, Goldberg GL. Critical review of the routine postoperative fever evaluation on a gynecologic surgery service. ACOG 1998 Junior Fellow Annual Meeting.
New York, NY.
Simon BJ, Valentine N, Bruck LR. A retrospective chart review of single dose methotrexate for the treatment of ectopic pregnancy at JacobiMedicalCenter from 1998-2001. 3rd World Congress on Controversies in Obstetrics, Gynecology and Infertility.Washington, DC.
Ng E, Damus K, Bruck LR, MacIsaac L. Advance provision of levonorgesterol-only emergency contraception versus prescription. ACOG 2003 annual meeting.
New Orleans, LA.
Bruck LR, Zee SY, Poulos BK, Carroll DA, Abadi M. Detection of cervical human papillomavirus infection by in-situ hybridization in fetuses of women with squamous intraepithelial lesions. The American Society for Colposcopy and Cervical Pathology 2004 Biennial Meeting.Orlando, FL.
Abadi MA, Kra J, Bruck LR. Detection of HPV in fetal larynx. 24th International HPV Meeting. Beijing, China.
Development of a bladeless tissue morcellator using plasma kinetic technology. Anderson TL, Bruck LR, Lyons TL Advincula AP. 36th Global Congress of Minimally Invasive Gynecology. Washington, DC.
lbruckPage 111/7/2018